| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Head - Established Brands
1 company
Rowland Thomas Andrew serves as a SVP, Head - Established Brands at ANIP. Across recent SEC filings that breaks down to 0 buys and 3 sells. Those positions are worth an estimated $3.0M at current prices.
The biggest single holding is ANIP (~$3.0M) as SVP, Head - Established Brands. The recent filings there lean toward selling, a net 10,206 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 12, 2026 | ANIP Ani Pharmaceuticals, Inc. | SVP, Head - Established Brands | Sell | 459 | $79.21 | $36,357.39 | -1.2% | -4.7% | - | |
| Mar 11, 2026 | ANIP Ani Pharmaceuticals, Inc. | SVP, Head - Established Brands | Sell | 4,772 | $74.91 | $357,470.52 | -11.0% | +6.4% | - | |
| Aug 12, 2025 | ANIP Ani Pharmaceuticals Inc | SVP, Head - Established Brands | Sell | 4,975 | $85.71 | $426,407.25 | -10.9% | +0.7% | -15.0% |